263 related articles for article (PubMed ID: 25519020)
21. Clinical and biological significance of miR-378a-3p and miR-378a-5p in colorectal cancer.
Li H; Dai S; Zhen T; Shi H; Zhang F; Yang Y; Kang L; Liang Y; Han A
Eur J Cancer; 2014 Apr; 50(6):1207-21. PubMed ID: 24412052
[TBL] [Abstract][Full Text] [Related]
22. MicroRNA expression patterns of tumors in early-onset colorectal cancer patients.
Ak S; Tunca B; Tezcan G; Cecener G; Egeli U; Yilmazlar T; Ozturk E; Yerci O
J Surg Res; 2014 Sep; 191(1):113-22. PubMed ID: 24746948
[TBL] [Abstract][Full Text] [Related]
23. MicroRNA and targeted mRNA expression profiling analysis in human colorectal adenomas and adenocarcinomas.
Gattolliat CH; Uguen A; Pesson M; Trillet K; Simon B; Doucet L; Robaszkiewicz M; Corcos L
Eur J Cancer; 2015 Feb; 51(3):409-20. PubMed ID: 25586944
[TBL] [Abstract][Full Text] [Related]
24. A panel of microRNA signature in serum for colorectal cancer diagnosis.
Zhu M; Huang Z; Zhu D; Zhou X; Shan X; Qi LW; Wu L; Cheng W; Zhu J; Zhang L; Zhang H; Chen Y; Zhu W; Wang T; Liu P
Oncotarget; 2017 Mar; 8(10):17081-17091. PubMed ID: 28177881
[TBL] [Abstract][Full Text] [Related]
25. A plasma microRNA panel for early detection of colorectal cancer.
Wang S; Xiang J; Li Z; Lu S; Hu J; Gao X; Yu L; Wang L; Wang J; Wu Y; Chen Z; Zhu H
Int J Cancer; 2015 Jan; 136(1):152-61. PubMed ID: 23456911
[TBL] [Abstract][Full Text] [Related]
26. Predictive microRNAs for lymph node metastasis in endoscopically resectable submucosal colorectal cancer.
Jung CK; Jung SH; Yim SH; Jung JH; Choi HJ; Kang WK; Park SW; Oh ST; Kim JG; Lee SH; Chung YJ
Oncotarget; 2016 May; 7(22):32902-15. PubMed ID: 27096956
[TBL] [Abstract][Full Text] [Related]
27. Plasma miR-601 and miR-760 are novel biomarkers for the early detection of colorectal cancer.
Wang Q; Huang Z; Ni S; Xiao X; Xu Q; Wang L; Huang D; Tan C; Sheng W; Du X
PLoS One; 2012; 7(9):e44398. PubMed ID: 22970209
[TBL] [Abstract][Full Text] [Related]
28. microRNA-221 and microRNA-18a identification in stool as potential biomarkers for the non-invasive diagnosis of colorectal carcinoma.
Yau TO; Wu CW; Dong Y; Tang CM; Ng SS; Chan FK; Sung JJ; Yu J
Br J Cancer; 2014 Oct; 111(9):1765-71. PubMed ID: 25233396
[TBL] [Abstract][Full Text] [Related]
29. Fecal miR-29a and miR-224 as the noninvasive biomarkers for colorectal cancer.
Zhu Y; Xu A; Li J; Fu J; Wang G; Yang Y; Cui L; Sun J
Cancer Biomark; 2016; 16(2):259-64. PubMed ID: 26756616
[TBL] [Abstract][Full Text] [Related]
30. Clinical potential role of circulating microRNAs in early diagnosis of colorectal cancer patients.
Du M; Liu S; Gu D; Wang Q; Zhu L; Kang M; Shi D; Chu H; Tong N; Chen J; Adams TS; Zhang Z; Wang M
Carcinogenesis; 2014 Dec; 35(12):2723-30. PubMed ID: 25239640
[TBL] [Abstract][Full Text] [Related]
31. Clinical significance of microRNA-21 as a biomarker in each Dukes' stage of colorectal cancer.
Fukushima Y; Iinuma H; Tsukamoto M; Matsuda K; Hashiguchi Y
Oncol Rep; 2015 Feb; 33(2):573-82. PubMed ID: 25421755
[TBL] [Abstract][Full Text] [Related]
32. Circulating microRNA-1290 as a novel diagnostic and prognostic biomarker in human colorectal cancer.
Imaoka H; Toiyama Y; Fujikawa H; Hiro J; Saigusa S; Tanaka K; Inoue Y; Mohri Y; Mori T; Kato T; Toden S; Goel A; Kusunoki M
Ann Oncol; 2016 Oct; 27(10):1879-86. PubMed ID: 27502702
[TBL] [Abstract][Full Text] [Related]
33. Genetic and epigenetic down-regulation of microRNA-212 promotes colorectal tumor metastasis via dysregulation of MnSOD.
Meng X; Wu J; Pan C; Wang H; Ying X; Zhou Y; Yu H; Zuo Y; Pan Z; Liu RY; Huang W
Gastroenterology; 2013 Aug; 145(2):426-36.e1-6. PubMed ID: 23583431
[TBL] [Abstract][Full Text] [Related]
34. Identification of microRNA-135b in stool as a potential noninvasive biomarker for colorectal cancer and adenoma.
Wu CW; Ng SC; Dong Y; Tian L; Ng SS; Leung WW; Law WT; Yau TO; Chan FK; Sung JJ; Yu J
Clin Cancer Res; 2014 Jun; 20(11):2994-3002. PubMed ID: 24691020
[TBL] [Abstract][Full Text] [Related]
35. Combined Plasma MicroRNA and Fecal Occult Blood Tests in Early Detection of Colorectal Cancer.
Luo X; Wu Y; Ji M; Zhang S
Clin Lab; 2019 May; 65(5):. PubMed ID: 31115212
[TBL] [Abstract][Full Text] [Related]
36. Global fecal microRNA profiling in the identification of biomarkers for colorectal cancer screening among Asians.
Phua LC; Chue XP; Koh PK; Cheah PY; Chan EC; Ho HK
Oncol Rep; 2014 Jul; 32(1):97-104. PubMed ID: 24841830
[TBL] [Abstract][Full Text] [Related]
37. MicroRNA signatures: novel biomarker for colorectal cancer?
Luo X; Burwinkel B; Tao S; Brenner H
Cancer Epidemiol Biomarkers Prev; 2011 Jul; 20(7):1272-86. PubMed ID: 21551242
[TBL] [Abstract][Full Text] [Related]
38. Differential expressions of cancer-associated genes and their regulatory miRNAs in colorectal carcinoma.
Kara M; Yumrutas O; Ozcan O; Celik OI; Bozgeyik E; Bozgeyik I; Tasdemir S
Gene; 2015 Aug; 567(1):81-6. PubMed ID: 25925209
[TBL] [Abstract][Full Text] [Related]
39. microRNA expression profile in stage III colorectal cancer: circulating miR-18a and miR-29a as promising biomarkers.
Brunet Vega A; Pericay C; Moya I; Ferrer A; Dotor E; Pisa A; Casalots À; Serra-Aracil X; Oliva JC; Ruiz A; Saigí E
Oncol Rep; 2013 Jul; 30(1):320-6. PubMed ID: 23673725
[TBL] [Abstract][Full Text] [Related]
40. The potential of plasma miRNAs for diagnosis and risk estimation of colorectal cancer.
Chen WY; Zhao XJ; Yu ZF; Hu FL; Liu YP; Cui BB; Dong XS; Zhao YS
Int J Clin Exp Pathol; 2015; 8(6):7092-101. PubMed ID: 26261602
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
